Trial Profile
A Phase 2, Multi-Center, Randomized, Evaluator-Blinded, Vehicle-Controlled Study Comparing the Efficacy, Tolerability, and Safety of SB204 Gel and Vehicle Gel Once or Twice Daily in the Treatment of Acne Vulgaris
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2023
Price :
$35
*
At a glance
- Drugs Berdazimer sodium (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Novan Inc
- 18 Oct 2016 According to a Novan Therapeutics media release, results from this trial will be presented at the 35th Anniversary Fall Clinical Dermatology Conference
- 28 Sep 2016 Results from this trial presented at the 74th Annual Meeting of the American Academy of Dermatology in March, as per Novan media release.
- 01 Mar 2016 According to a Novan Therapeutics media release, results from this trial will be presented at the 74th Annual Meeting of the American Academy of Dermatology ("AAD")